Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Activating cannabinoid receptor 1 may help manage psoriasis by reducing certain keratins.

A mutation in the iRhom2 gene causes hairless mice due to abnormal hair follicle development.

The document confirms the structures of major metabolites of the CRTh2 antagonist Setipiprant and identifies minor metabolites.

5α-reductases increase epitestosterone's effect on androgen receptors.

Transferrin receptor 1 is essential for normal function in the intestines, pancreas, and skin.

mTORC2 is crucial for healthy skin barrier by regulating lipids and filaggrin.

Delta opioid receptors help regulate touch sensation by reducing neurotransmitter release in the spinal cord.

ROS may affect hair loss related to hormones.

AKR1B10 enzyme may cause keloid scars and could be a treatment target.

Estrogen affects how vitamin A is processed in mouse skin, which may impact acne treatment, hair growth, and skin defense.

MicroRNAs are crucial in controlling cell signaling, affecting cancer and tissue regeneration.

New treatments for prostate cancer are less toxic and show promise, but more research is needed to enhance their effectiveness and reduce side effects.

Increasing calcium sensing receptor speeds up skin and hair development in mice.

Keratin 6A increases skin inflammation, suggesting it could be a target for treating certain skin diseases.

PROTAC technology shows promise for cancer treatment but needs more effective E3 ligase recruiters.

Thyroid hormone receptor β1 is found in human hair follicles and helps them survive.

Lecithin-encapsulated resveratrol nanoparticles could be a safe and effective anti-cancer treatment.

PRC1 is essential for proper skin development and stem cell formation by controlling gene activity.

Glucocorticoids reduce fat production in liver cells, while androgens increase it in females; manipulating certain enzymes can influence these effects.

mrp/plf-mRNA can indicate tumor-promoting effects in skin.

Certain histamine receptors (H2R, H3R, H4R) have unique roles in treating skin diseases, with H2R helping with chronic urticaria and other conditions, H3R providing pain relief and allergy benefits, and H4R reducing inflammation and itchiness.

CREB, a protein that can promote cancer traits, is controlled by β-catenin in skin cancer cells.

TLR-targeted therapies show promise in cancer treatment by helping destroy tumors.

Genetically modified rats help reveal how vitamin D affects bone and skin health.

EGFR cancer drugs often cause a rash, which can lead to distress and isolation, but may also improve outcomes for some cancer patients. Current treatments for the rash are limited, but a compound called menadione shows promise.

The document concludes that DAB389-IL2 is promising for treating refractory cutaneous T-cell lymphoma, but more research is needed on its effectiveness and side effect management.

Damage to skin releases dsRNA, which activates TLR3 and helps in skin and hair follicle regeneration.

Four patients with a type of rickets and hair loss had different mutations in their vitamin D receptor gene, causing it to not work properly.

Vitamin D receptor is crucial for normal hair growth and preventing hair loss.